Consensus IMAC Holdings, Inc.

Equities

BACK

US44967K3023

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
3.3 ^USD	-2.37%		+2.80%	+49.32%

May. 06	Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	CI
Apr. 16	IMAC Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on IMAC Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fd2910cb5f72d94d595eb34f84ad563._pLbPo5OGuAMrZRItue6y4ZbVveKSDGHbSICGSrkh-w.naWyc-M3UrpP3-IA_srXlOcKYdraAwjBGGBBcnKO5rrTyIlq5H5_t1v4-w~2a1ec17cd3aa49da4de7a9d4cdd4bb09

Analyst Recommendations on IMAC Holdings, Inc.

IMAC : National Alliance Securities Downgrades IMAC Holdings to Neutral Rating From Buy, Adjusts Price Target to $1.75 From $2.35	21-08-19	MT
IMAC : Alliance Global Adjusts IMAC Holdings' Price Target to $2.35 From $3.10, Maintains Buy Rating	21-04-09	MT
IMAC : Alliance Global Starts IMAC Holdings at Buy With $2.75 Price Target	20-11-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.3 USD

Average target price

8 USD

Spread / Average Target

+142.42%

High Price Target

8 USD

Spread / Highest target

+142.42%

Low Price Target

8 USD

Spread / Lowest Target

+142.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IMAC Holdings, Inc.

National Alliance Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar